Financials Medclair AB

Equities

MCLR

SE0009190572

Industrial Machinery & Equipment

End-of-day quote NORDIC GROWTH MARKET 03:30:00 15/05/2024 am IST 5-day change 1st Jan Change
1.195 SEK -1.24% Intraday chart for Medclair AB +3.91% -28.78%

Valuation

Fiscal Period: December 2020 2021 2022
Capitalization 1 64.12 221.9 102.6
Enterprise Value (EV) 1 64.97 203.1 99.62
P/E ratio - -16.8 x -20.7 x
Yield - - -
Capitalization / Revenue 10 x 16.7 x 3.64 x
EV / Revenue 10.1 x 15.2 x 3.54 x
EV / EBITDA -61.7 x -22.7 x 255 x
EV / FCF -7,21,59,467 x -3,03,34,337 x -1,13,12,669 x
FCF Yield -0% -0% -0%
Price to Book - 3.84 x 1.95 x
Nbr of stocks (in thousands) 60,492 82,492 82,492
Reference price 2 1.060 2.690 1.244
Announcement Date 01/03/21 22/03/22 20/04/23
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 5.357 5.294 5.813 6.412 13.32 28.17
EBITDA 1 -1.47 -1.057 -2.362 -1.053 -8.935 0.391
EBIT 1 -2.036 -1.903 -3.442 -1.693 -12.9 -3.695
Operating Margin -38% -35.95% -59.21% -26.4% -96.89% -13.12%
Earnings before Tax (EBT) 1 -2.08 -1.908 -3.588 -2.009 -13.01 -4.987
Net income 1 -2.08 -1.908 -3.588 -2.009 -13.02 -5
Net margin -38.83% -36.04% -61.72% -31.33% -97.76% -17.75%
EPS - - - - -0.1600 -0.0600
Free Cash Flow - - - -0.9004 -6.694 -8.806
FCF margin - - - -14.04% -50.26% -31.26%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 23/05/18 06/04/20 06/04/20 01/03/21 22/03/22 20/04/23
1SEK in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q2 2022 Q3 2022 Q4
Net sales 1 - 2.856 9.307
EBITDA 1 - -2.741 3.39
EBIT 1 - -4.266 1.11
Operating Margin - -149.37% 11.93%
Earnings before Tax (EBT) - - -
Net income -2.532 - -
Net margin - - -
EPS -0.0300 - -
Dividend per Share - - -
Announcement Date 11/08/22 03/11/22 22/02/23
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - - - 0.85 - -
Net Cash position 1 0.13 0.22 0.29 - 18.8 3.01
Leverage (Debt/EBITDA) - - - -0.8063 x - -
Free Cash Flow - - - -0.9 -6.69 -8.81
ROE (net income / shareholders' equity) -178% -257% -141% -9.2% -26.8% -9.05%
ROA (Net income/ Total Assets) -33% -23.1% -31.8% -3.96% -14.6% -3.6%
Assets 1 6.298 8.27 11.28 50.72 89.17 139.1
Book Value Per Share - - - - 0.7000 0.6400
Cash Flow per Share - - - - 0.2500 0.0500
Capex - - - - - 0.31
Capex / Sales - - - - - 1.09%
Announcement Date 23/05/18 06/04/20 06/04/20 01/03/21 22/03/22 20/04/23
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. MCLR Stock
  4. Financials Medclair AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW